PALI
PALISADE BIO, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.59
−6.47%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.06
- Revenue estimate
- $465.3K
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.05
- EPS estimate
- -$0.05
- Revenue actual
- $500.0K
- Revenue estimate
- $500.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -13.9%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.05 | -$0.05 | Beat 4.25% | $500.0K |
| May 12, 2026 | -$0.04 | -$0.05 | Miss -25.00% | — |
| Mar 23, 2026 | -$0.02 | -$0.04 | Miss -100.00% | — |
| Mar 24, 2025 | -$1.99 | -$0.69 | Beat 65.33% | $4.0K |
| Nov 9, 2023 | -$0.39 | -$7.35 | Miss -1784.62% | — |
| Aug 11, 2023 | -$0.45 | -$7.95 | Miss -1666.67% | — |
| May 12, 2023 | -$0.72 | -$8.10 | Miss -1025.00% | $250.0K |
| Mar 22, 2023 | -$2.43 | $6.47 | Beat 366.26% | — |
| Nov 14, 2022 | -$4.00 | -$60 | Miss -1399.25% | — |
| Aug 15, 2022 | -$8.50 | -$90 | Miss -958.35% | — |
| May 13, 2022 | -$210 | -$195 | Beat 7.19% | — |
| Mar 16, 2022 | -$12 | $555 | Beat 4821.02% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026